Results for tag: "Emsam"

Emsam is a brand of transdermal selegiline, a drug used to treat major depressive disorder. It is the first and only transdermal patch approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder. The patch is applied to the skin and delivers selegiline directly into the bloodstream, providing a steady dose of the drug throughout the day. Emsam is an effective treatment for major depressive disorder, with studies showing that it can reduce symptoms of depression and improve quality of life. Emsam is part of a larger market of mental disorder drugs, which includes antidepressants, antipsychotics, and mood stabilizers. These drugs are used to treat a variety of mental health conditions, including depression, anxiety, bipolar disorder, and schizophrenia. Companies in the Emsam market include Somerset Pharmaceuticals, which manufactures the Emsam patch, as well as pharmaceutical companies such as Pfizer, Eli Lilly, and GlaxoSmithKline, which produce other mental disorder drugs. Show Less Read more